Literature DB >> 3918981

Isolation and characterization of bulgecins, new bacterial metabolites with bulge-inducing activity.

S Shinagawa, M Maki, K Kintaka, A Imada, M Asai.   

Abstract

Bulgecins A, B and C, new bacterial metabolites which induce the formation of bulges by cooperation with beta-lactam antibiotics, were isolated from the culture broth of Pseudomonas mesoacidophila. The three components, separated by column chromatography on QAE-Sephadex A-25, are water-soluble acidic compounds containing a sulfate group in the molecule. Acid hydrolysis showed that D-glucosamine and a new proline derivative are common constituents of the three components. In addition, taurine and beta-alanine are constituents of bulgecins A and B, respectively.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3918981     DOI： 10.7164/antibiotics.38.17

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


  11 in total

Review 1.  Constructing and deconstructing the bacterial cell wall.

Authors:  Jed F Fisher; Shahriar Mobashery
Journal:  Protein Sci       Date:  2019-11-20       Impact factor: 6.725

2.  Anti-bacterial glycosyl triazoles - Identification of an N-acetylglucosamine derivative with bacteriostatic activity against Bacillus.

Authors:  Helene Kuhn; Danielle Gutelius; Eimear Black; Christina Nadolny; Amit Basu; Christopher Reid
Journal:  Medchemcomm       Date:  2014-08       Impact factor: 3.597

3.  Bulgecin A: a novel inhibitor of binuclear metallo-beta-lactamases.

Authors:  Alan M Simm; E Joel Loveridge; John Crosby; Matthew B Avison; Timothy R Walsh; Peter M Bennett
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

Review 4.  Lytic transglycosylases: concinnity in concision of the bacterial cell wall.

Authors:  David A Dik; Daniel R Marous; Jed F Fisher; Shahriar Mobashery
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-06-23       Impact factor: 8.250

5.  Novel morphological changes in gram-negative bacteria caused by combination of bulgecin and cefmenoxime.

Authors:  M Nakao; K Yukishige; M Kondo; A Imada
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

6.  (2S,3R,4R,5R)-3,4-Dihydr-oxy-5-(hydroxy-meth-yl)pyrrolidine-2-carboxylic acid [(2S,3R,4R,5R)-3,4-dihydr-oxy-5-(hydroxy-meth-yl)proline].

Authors:  Daniel Best; Sarah F Jenkinson; Amber L Thompson; David J Watkin; Francis X Wilson; Robert J Nash; George W J Fleet
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-09-09

7.  Bulgecin A as a β-lactam enhancer for carbapenem-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii clinical isolates containing various resistance mechanisms.

Authors:  Marion J Skalweit; Mei Li
Journal:  Drug Des Devel Ther       Date:  2016-09-20       Impact factor: 4.162

8.  Whole-Genome Shotgun Sequencing of Two β-Proteobacterial Species in Search of the Bulgecin Biosynthetic Cluster.

Authors:  Mark E Horsman; Daniel R Marous; Rongfeng Li; Ryan A Oliver; Byungjin Byun; Scott J Emrich; Bill Boggess; Craig A Townsend; Shahriar Mobashery
Journal:  ACS Chem Biol       Date:  2017-09-26       Impact factor: 5.100

9.  Reclassification of the Specialized Metabolite Producer Pseudomonas mesoacidophila ATCC 31433 as a Member of the Burkholderia cepacia Complex.

Authors:  E Joel Loveridge; Cerith Jones; Matthew J Bull; Suzy C Moody; Małgorzata W Kahl; Zainab Khan; Louis Neilson; Marina Tomeva; Sarah E Adams; Andrew C Wood; Daniel Rodriguez-Martin; Ingrid Pinel; Julian Parkhill; Eshwar Mahenthiralingam; John Crosby
Journal:  J Bacteriol       Date:  2017-06-13       Impact factor: 3.490

10.  Total Syntheses of Bulgecins A, B, and C and Their Bactericidal Potentiation of the β-Lactam Antibiotics.

Authors:  Shusuke Tomoshige; David A Dik; Masaaki Akabane-Nakata; Chinedu S Madukoma; Jed F Fisher; Joshua D Shrout; Shahriar Mobashery
Journal:  ACS Infect Dis       Date:  2018-05-07       Impact factor: 5.084
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.